JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 30, 2007; DOI: 10.1124/jpet.107.119628


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.119628v1
322/2/789    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cherian, L.
Right arrow Articles by Robertson, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cherian, L.
Right arrow Articles by Robertson, C. S.


Received for publication January 11, 2007.
Revised April 26, 2007.
Accepted for publication April 27, 2007.

Neuroprotection with Erythropoietin Administration Following Controlled Cortical Impact Injury in Rats

Leela Cherian 1*, Clay Jerry Goodman 2, Claudia Sue Robertson 2

1 Baylor college of Medicine 2 Baylor College of Medicine

* Address correspondence to: E-mail: lcherian{at}bcm.tmc.edu

Abstract

This study was designed to determine the effect of erythropoietin (Epo) on cerebral blood flow (CBF), nitric oxide (NO) concentration and on neurological outcome after traumatic brain injury. In one experiment, the hemodynamic effects of Epo were determined after controlled cortical impact injury (CCII) by measuring mean arterial pressure (MAP), intracranial pressure (ICP), CBF using laser Doppler flowmetry (LDF), and brain tissue NO concentrations using an NO electrode. A total of 41 rats were given either Epo (5000units/kg) or saline SC three days prior to injury. In animals pretreated with saline, L-arginine but not D-arginine administration resulted in a significant increase in tissue NO concentrations and an improvement in CBF at the impact site. Similarly, in animals pretreated with Epo, L-arginine but not D-arginine given post-injury increased brain tissue NO concentrations and increased CBF. In another experiment, 74 rats underwent CCII (3mm deformation, velocity 5m/sec) and were given saline or erythropoietin (Epo) 5000 units/kg SC at 5min, 1hr, 3hr, 6hr, 9hr, or 12hr post injury. The contusion volume and cell counts of viable neurons in the CA1 and CA3 regions of the hippocampus were assessed at 2 weeks post-injury. The contusion volume was significantly reduced at 5min, 1hr, 3hr and 6hr post injury EPO administration. The neuron density in the CA1and CA3 region of the hippocampus was increased at 1hr, 3hr, and 6hr after injury. These data demonstrate the neuroprotective effects of Epo in traumatic injury and the effects are optimal when Epo is given within 6 hrs of injury.


Key words: Cerebral blood flow, Neuroprotection, Nitric Oxide, cortical impact injury, erythropoietin, traumatic brain injury





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.